What is the management for a patient with conjunctival watery discharge, photosensitivity, and pain suggestive of herpetic keratitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Herpetic Keratitis

For a patient presenting with conjunctival watery discharge, photosensitivity, and pain suggestive of herpetic keratitis, initiate combination therapy with topical antiviral (preferably ganciclovir 0.15% gel 3-5 times daily) plus oral antiviral therapy (acyclovir 200-400 mg five times daily, valacyclovir 500 mg 2-3 times daily, or famciclovir 250 mg twice daily). 1

First-Line Treatment Approach

Topical Antiviral Selection

  • Ganciclovir 0.15% gel is the preferred topical agent due to superior ocular surface tolerability and minimal toxicity with prolonged use 1
  • Apply 3-5 times daily until epithelial healing occurs 2, 1
  • Alternative: Trifluridine 1% solution 5-8 times daily, but this agent causes inevitable epithelial toxicity if used beyond 2 weeks 2, 1

Oral Antiviral Therapy

The American Academy of Ophthalmology recommends adding oral antivirals to topical therapy: 1

  • Acyclovir 200-400 mg five times daily 2, 1
  • Valacyclovir 500 mg two to three times daily 2, 1
  • Famciclovir 250 mg twice daily 2, 1

Oral antivirals alone may not adequately prevent progression of HSV blepharoconjunctivitis, making the combination with topical therapy essential 2

Critical Management Principles

What to Avoid

  • Never use topical corticosteroids without concurrent antiviral coverage in epithelial HSV keratitis, as steroids potentiate HSV infection and can worsen the condition 2, 1
  • Avoid prolonged trifluridine use (>2 weeks) due to epithelial toxicity 2, 1

When Steroids Are Indicated

If secondary HSV stromal keratitis develops, topical steroids may be beneficial but must always be used in conjunction with oral antiviral therapy to prevent viral replication 2, 1

Follow-Up Protocol

Schedule follow-up within 1 week of initiating treatment to assess: 2, 1

  • Reduced pain and discharge 1
  • Decreased corneal infiltrate density 1
  • Initial re-epithelialization 1
  • Visual acuity measurement 2
  • Slit-lamp biomicroscopy 2

Clinical Pearls

Diagnostic Features

The combination of watery discharge, photosensitivity (photophobia), and pain with vesicular lid lesions and dendritic corneal lesions are highly suggestive of herpes simplex 3

Natural History

HSV conjunctivitis is typically self-limited, subsiding within 4-7 days without treatment unless complications develop 3, but treatment should still be initiated promptly upon high suspicion or with concomitant corneal involvement 2

Potential Complications to Monitor

  • Epithelial keratitis 3
  • Stromal keratitis 3
  • Endotheliitis 3
  • Corneal scarring, thinning, or perforation 3
  • Neurotrophic keratopathy from recurrent infections 1

Long-Term Prophylaxis Considerations

For patients with recurrent disease, lower doses of oral antivirals are considered for long-term prophylaxis against recurrent HSV keratitis 2. After penetrating keratoplasty or in cases of severe recurrences, systemic acyclovir 400 mg twice daily for at least 1 year is recommended 4, 5

References

Guideline

Treatment of Herpetic Keratitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Herpes Simplex Viral Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

["Herpetic keratitis". Various expressions require different therapeutic approaches].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.